Review
Open access
Aug 2026
Myeloid-derived suppressor cells in laryngeal squamous cell carcinoma: an underexplored immunosuppressive axis and strategic target for overcoming checkpoint inhibitor resistance
It is argued that combining MDSC-targeting strategies with PD-1 blockade merits dedicated clinical investigation in this disease and supported MDSCs as a clinically tractable immunosuppressive node in LSCC.
Guan-Jiang Huang, Xue-Sen Yang, Peijie Li et al.
· Frontiers in Immunology · 1 citation